Dorman Products, Inc. New (DORM)
Company finances score is above the middle — score for how it compares with the broader market is on the low side.
DORM scores higher than 61% of the 653 tickers we compare it with (Consumer Discretionary).
As of 10 October 2026, Dorman Products, Inc. New (DORM) scores 47 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 1.05× 30-day average
- 52-week range
- 98.44 – 164.00
- Market cap
- $3.63B
- Earnings date
- 26 Oct 2026
- Volume
- 233,426
- Avg. volume (30d)
- 222,485
- Open
- 122.04
- Previous close
- 121.67
- Day's range (regular session)
- 120.00 – 122.60
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 1.03
- P/E (TTM)
- 16.46
- EPS (TTM)
- 7.22
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for DORM
- 11 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for DORM. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about DORM right now
Dorman Products, Inc. New (DORM) currently scores 47/100 on the Market Census six-factor composite, at the Average score level. DORM is -1.04% on the day and -2.16% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in DORM's data roughly balance out right now. DORM's strongest factor is company finances at 70/100 — a strong read on the company's own reported numbers. A high reading doesn't promise a near-term move. The weakest factor is strength vs the market at 31/100 — below average next to the wider market.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See DORM in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent DORM news
Latest headlines that name Dorman Products, Inc. New, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Dorman Products, Inc. Announces Date to Report Third Quarter 2026 Financial ResultsYahoo
- Wall Street Analysts Think Dorman Products (DORM) Could Surge 26.02%: Read This Before Placing a BetYahoo
- Dorman Products Has Proven Me Wrong (Upgrade)SeekingAlpha
- Dorman Products, Inc. (DORM) Q2 2026 Earnings Call TranscriptSeekingAlpha
- Dorman Prods Reports Q2 2026 Results: Full Earnings Call TranscriptBenzinga
We hide 2 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Consumer Discretionary right now
Six consumer discretionary tickers whose composite scores are closest to DORM’s 47, all within 1 point.
Sorted by closeness to DORM’s composite score within Consumer Discretionary. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.